How Many Nodules Should I Report To TIRADS?

Thyroid nodules have been discovered to be affecting a significant proportion of the population. It appears as a form of lumps or growths in the thyroid gland that’s situated at the lowermost part of the neck.

These nodules are usually detected when individuals run their routine check-ups or imaging studies. The nodules may be of different composition, shape and size.

Most of these nodules do not exert any negative change on your health as an individual, although a few of them can cause serious problems, and may require further testing or evaluation.

One primary tool used in discovering thyroid nodules is the Ultrasound imaging.

Meanwhile a system of categorization called TIRADS- Thyroid Imaging, Reporting, and Data System is used in examining the risk of malignancy in thyroid nodules on the basis of its ultrasound characteristics.

Meanwhile, this article will be providing you with answers on how many nodules you should report to TIRADS as you discover it in your body.

When trying to identify the nodules to report as an individual, it’s important that you prioritize your choices of report on the basis of their ultrasound features as associated with how high their risk of malignancy is.

Meanwhile, there’s a point scoring system as determined from the five categories of ultrasound classification. It’s such that the higher the cumulative score, the higher the TR (TI-RADS) level and the likelihood of malignancy.

In cases where multifold nodules are identified, only the four highest-scoring nodules should be scored, reported, and followed up; although it may not necessarily be the biggest. More so, in cases where cystic or spongiform nodules are predominant, it’s inherently benign and no further points will be added since it automatically falls in the TR1 category.

In other words, you may have to report to TIRADS when you have up to four of the most suspicious nodules within your thyroid gland. This report strategy is to help you ensure that the most clinically significant nodules are assessed without the need to unnecessarily examine the benign nodules.

For more information, check out here and here.

Different Categories and their Scoring Points

TR1: 0 points indicate benign.
TR2: 2 points indicate not suspicious.
TR3: 3 points indicate mildly suspicious.
TR4: 4 to 6 points indicate moderately suspicious.
TR5: Greater than or equal to 7 points indicate highly suspicious.

Conclusion

Making the decision on how many thyroid nodules to report to TIRADS should be seriously prioritized by the identification of suspicious ultrasound characteristics and the potential risk of malignancy.

More so, if multifold nodules share the same suspicious characteristics, it’s important to report the largest ones so that critical focus will be on those nodules that are more likely to impact your management and outcomes as a patient.

Though not all nodules must be reported to TIRADS, nevertheless they must be adequately and regularly monitored via ultrasound imaging, because further evaluation and reporting may become necessary at some points when changes in the size, shape, or characteristics of these nodules are observed.

Hence, getting to know the procedures for reporting thyroid nodules to TIRADS can assist you in making informed decisions and effectively manage thyroid health as a patient.

Related:

Reference

Sakajiri RK, Rahal Junior A, Francisco Neto MJ, Queiroz MRG, Garcia RG, Martins LAL, Malerbi DAC. Ultrasound classification of thyroid nodules: does size matter? Einstein (Sao Paulo). 2022 May 16;20:eAO6747. doi: 10.31744/einstein_journal/2022AO6747. PMID: 35584446; PMCID: PMC9094606.
Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med.1968;69(3):537-40. [DOI] [PubMed]
Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist. 2007;12(1):20-37 [Epidemiology and Population Studies: SEER Series]. [DOI] [PubMed]
Coeli CM, Brito AS, Barbosa FS, Ribeiro MG, Sieiro AP, Vaisman M. Incidência e mortalidade por câncer de tireóide no Brasil. Arq Bras Endocrinol Metab. 2005;49(4):503-9. [DOI] [PubMed]
Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, Lim HK, Moon WJ, Na DG, Park JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, Kim DW, Kim EK, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, Lee KH, Park SW, Sung JY; Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Ultrasonography diagnosis and imaging-based management of thyroid nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol. 2016;17(3):370-95. Review. [DOI] [PMC free article] [PubMed]
Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587-95. [DOI] [PubMed]
6.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. [DOI] [PMC free article] [PubMed]

0 Shares

How Many Nodules Should I Report To TIRADS?

Table of Contents